Funding Opportunities

For the past 42 years, the mission of the NHF has been to further awareness of headache and migraine as legitimate neurobiological diseases. Science has changed since that time, and with advances in technology and clinical innovation there are more treatment options than ever before.

The NHF supports research in the field of headache and pain. NHF seeks research protocols that are objectively sound and whose results can contribute to the better understanding and treatment of headache and pain.

The Department of Health and Human Services is the US Government's principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves.

HHS represents almost a quarter of all federal outlays and it administers more grant dollars than all other federal agencies combined. For a complete list of grants available, visit grants.gov.

The Hearing Health Foundation is the largest private funding source of hearing research, with a mission to prevent and cure hearing loss through groundbreaking research. Since 1958, the Hearing Health Foundation has given over $27.8 million through more than 2,000 grants to hearing and balance research, leading to dramatic innovations to those living with hearing loss, while protecting those at risk.

With the potential of hearing restoration through regeneration biology, the scope of funded research has greatly expanded, supporting research in the areas of fundamental auditory research, hearing and balance restoration, cochlear implants, hearing loss, vestibular and balance disorders, tinnitus, and hyperacusis.

Dedicated to finding better treatments and cures for hemophilia and preventing complications of these disorders through education, advocacy, and research, Programs and initiatives are made possible through individuals, corporations, and foundations, as well as a cooperative agreement with the CDC.

NHF awards grants to fund innovative research to find better treatments and cures for bleeding disorders. This research has led to greater insight into improved factor replacement therapies, more accurate diagnostic methods and a greater understanding of the genetic basis of hemophilia.

Awards offered by NHF include:

• NHF-Baxter Clinical Fellowship - Intended to increasing the number of skilled clinicians committed to providing comprehensive care for individuals with bleeding and clotting disorders. Award recipients are able to receive up to $200,000 for a maximum period of two years.
• NHF/Novo Nordisk Career Development Award - Must hold an MD, PhD, or equivalent degree, with no more than six years of post-doctoral experience, or greater than six years completing medical training. US citizenship is not required, but applicants must be affiliated with or be faculty members of domestic organizations such as universities, colleges, hospitals, or laboratories.
• Judith Graham Pool Post-Doctoral Research Fellowship - Candidates must have completed doctoral training and apply for the fellowship award from a doctoral, post-doctoral, internship, or residency training program. Those with more than six years of experience since completing doctoral training are not eligible.

The Humana Foundation promotes healthy lives and healthy communities and believes that improved health and education provide the greatest opportunities to enhance the quality of life for both individuals and the community. They have confidence in people and their capacity to change for the better.

Funding priorities include projects related to childhood health, including supporting efforts improving physical activity and nutritional habits of children and families, intergenerational health, and active lifestyles. The Foundation also funds projects that are conducted in areas where Humana has a significant business persona, are innovative and replicable, are sustainable and provide measurable outcomes, and are completed one year to 18 months after start date.

The objectives of the foundation include: support of research, family education and service, public outreach and education, support of parents of children and adults, support of training for growth specialist, and education of the medical profession.

The focus and emphasis of the Foundation objectives vary with the opportunities to provide support, services, and education to children with growth disorders and adults with growth hormone deficiency.

Support of research is provided to the Foundation's Small Grant Program, which is funded by an endowment.

Seeking to improve the health and health care of all Americans, the Robert Wood Johnson Foundation provides grants for projects in the US that advance that mission. In 2011, approximately $400 million in grants were awarded in seven program areas:

• Childhood obesity - Looking to reverse this epidemic by 2015 by improving access to healthy foods and increasing opportunities for physical activity in schools and communities.
• Coverage - Working to ensure that nearly all Americans have stable, affordable health coverage by 2020.
• Human capital - Preparing health professionals for leadership, support scholars in their research, and promote diversity in order to build a skilled health care workforce.
• Pioneer - Supporting projects that use original, unconventional approaches, leading to breakthrough ideas that can shape the future of health and health care.
• Public health - Working to improve the nation's public health system, both governmental and non-governmental through research, community partnerships, and actions.
• Quality / Equality - Committed to reducing health care disparities and improving the quality of health care for all Americans.
• Vulnerable populations - Seeking and nurturing game-changing ideas for improving the health of people whose social circumstances create the challenges for living healthy, successful lives.

The Pioneer Portfolio accepts unsolicited proposals for projects that suggest new and creative approaches to solving health and health care problems. Awards are given throughout the year and there are no deadlines.

To date, JDRF has awarded more than $1.6 billion to diabetes research. More than 80 percent of JDRF's expenditures directly support research and research-related education. Research goals are patient focused and are committed to curing, treating, and preventing Type 1 Diabetes.

Since its founding in 1970, JDRF has established a research program with a focus on people living with Type 1 Diabetes and their families. The amount of research that JDRF has increased from a few hundred thousand to more than $110 million in 2012.

Primary objectives for funding include beta cell therapies, immune therapies, glucose control, complications therapies, and prevention of Type 1 Diabetes.